Cannassure Therapeutics Ltd
CannAssure Ltd cultivates and produces medical cannabis. The company was incorporated in 2017 and is headquartered in Ashdod, Israel.
Market Cap & Net Worth: Cannassure Therapeutics Ltd (CSURE)
Cannassure Therapeutics Ltd (TA:CSURE) has a market capitalization of $100.82 Million (ILA37.61 Billion) as of March 18, 2026. Listed on the TA stock exchange, this Israel-based company holds position #48747 globally and #474 in its home market, demonstrating a -0.68% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Cannassure Therapeutics Ltd's stock price ILA735.00 by its total outstanding shares 51166800 (51.17 Million).
Cannassure Therapeutics Ltd Market Cap History: 2015 to 2026
Cannassure Therapeutics Ltd's market capitalization history from 2015 to 2026. Data shows growth from $16.37 Million to $100.82 Million (21.19% CAGR).
Cannassure Therapeutics Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Cannassure Therapeutics Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of CSURE by Market Capitalization
Companies near Cannassure Therapeutics Ltd in the global market cap rankings as of March 18, 2026.
Key companies related to Cannassure Therapeutics Ltd by market ranking:
- LabGenomics Co. Ltd (KQ:084650): Ranked #24330 globally with a market cap of $25.72 Million USD ( ₩37.66 Billion KRW).
- Las Condes (SN:LASCONDES): Ranked #40485 globally with a market cap of $126.42K USD ( CL$127.04 Million CLP).
- Shifa International Hospitals Ltd (KAR:SHFA): Ranked #44147 globally with a market cap of $16.57K USD ( PKRs4.62 Million PKR).
- Bonzun AB (ST:BONZUN): Ranked #45272 globally with a market cap of $8.22K USD ( Skr92.23K SEK).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #24330 | LabGenomics Co. Ltd | KQ:084650 | $25.72 Million | ₩1386.00 |
| #40485 | Las Condes | SN:LASCONDES | $126.42K | CL$13650.00 |
| #44147 | Shifa International Hospitals Ltd | KAR:SHFA | $16.57K | PKRs474.18 |
| #45272 | Bonzun AB | ST:BONZUN | $8.22K | Skr9.50 |
Cannassure Therapeutics Ltd Historical Marketcap From 2015 to 2026
Between 2015 and today, Cannassure Therapeutics Ltd's market cap moved from $16.37 Million to $ 100.82 Million, with a yearly change of 21.19%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ILA100.82 Million | +0.99% |
| 2025 | ILA99.84 Million | -7.30% |
| 2024 | ILA107.70 Million | +1525.47% |
| 2023 | ILA6.63 Million | -13.13% |
| 2022 | ILA7.63 Million | +39.70% |
| 2021 | ILA5.46 Million | -62.02% |
| 2020 | ILA14.38 Million | -5.84% |
| 2019 | ILA15.27 Million | -38.17% |
| 2018 | ILA24.69 Million | +128.72% |
| 2017 | ILA10.80 Million | -3.91% |
| 2016 | ILA11.23 Million | -31.35% |
| 2015 | ILA16.37 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Cannassure Therapeutics Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $100.82 Million USD |
| MoneyControl | $100.82 Million USD |
| MarketWatch | $100.82 Million USD |
| marketcap.company | $100.82 Million USD |
| Reuters | $100.82 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.